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ABSTRACT 
The author’s institute in Cambodia utilises Peer Educators (PEs) to screen and manage 
diabetes and hypertension in the community; a revolving drug fund (RDF) is used to finance 
the programme. Clinical outcomes and retention in the program are necessary to know if 
implementation of this program is to be widespread. We analysed clinical outcomes and 
patient retention in the programme between 2007-2016 in Takeo, Cambodia. For all those 
enrolled in the programme, the average change in blood pressure (BP) and percentage with 
controlled hypertension (BP < 140 / < 90 mmHg) or diabetes (fasting blood glucose (BG) < 
7mg/dl, post-prandial BG < 130mg/dl, or HBA1C < 7%) was calculated every 6 months from 
enrolment.  Attrition rate in the nth year of enrolment was calculated; associations with loss 
to follow-up were explored using cox regression. 9139 patients enrolled between January 
2007 and March 2016. For all hypertensives, mean change in systolic and diastolic BP within 
the first year was -15.1mmHg (SD 23.6, p <0.0001) and -8.6mmHg (SD 14.0, p <0.0001), 
respectively. BP control was 50.5% at year 1, peaking at 70.6% at 5.5 years. 41.3% of 
patients with diabetes achieved blood sugar control at 6 months and 44.4% at 6.5 years.  An 
average of 2.3 years [SD 1.9] was spent in programme. Attrition rate within year 1 of 
enrolment ranged from 29.8% to 61.5% with average of 44.1% [SD 10.3] across 2008-2015. 
Patients with hypertension were more likely to leave the program compared to those with 
diabetes and males more likely than females. The programme shows a substantial and 
sustained rate of diabetes and hypertension control for those who remain in the program 
and could be a model for implementation in other low middle-income settings, however, 
further work is needed to improve patient retention. 
INTRODUCTION: 
The global aim of achieving Universal Health Coverage (UHC) requires innovative, wide-
reaching interventions that improve access to care for vulnerable populations. Ageing 
populations, globalisation, reduction in physical activity, and changing diets have led to a 
rapid rise in non-communicable diseases (NCDs) against a backdrop of prevalent infectious 
diseases in many lower- and middle-income countries (LMICs). Cambodia, a LMIC in South 
East Asia, has a rapidly growing economy with aims to reach upper-middle income country 
status by 2030. Although poverty rates are falling, 4.5 million of the population of over 16 
million remain in near poverty and are vulnerable (World Bank, 2020). Life expectancy at 
birth was 72.7 years and 66.8 years for females and males, respectively, in 2017; an increase 
of 20 years in the last two decades (IHME, 2017). As expected with rapid economic 
development, NCDs are becoming prevalent. NCDs accounted for 64% of all deaths in 2018, 
and in 2016 stroke was the leading cause of death with ischaemic heart disease ranked as 
fourth (WHO, 2018). Type-2 diabetes mellitus and hypertension - modifiable risk factors for 
these conditions – were found in  5.9% and 11.2% of the population, respectively, in 2016 
(WHO, 2016; Sophal Oum, 2010), making them high-priority conditions to start tackling NCD 
morbidity and mortality. Despite this, in 2018,  fewer than 25% of primary health centres 
reported to offer cardiovascular disease (CVD) risk factor stratification, guidelines for CVD 
prevention were not used in more than 50% of facilities, and only 30% of facilities reported 
medicines for treating NCDs were generally available (WHO, 2018). Data from countries in 
South East Asia has shown that fewer than 40% of the population with hypertension have 
been diagnosed and fewer than 10% have this controlled to target (Geldsetzer et al., 2019). 
The figures are only slightly better for people with diabetes (Manne-Goehler et al., 2019).  In 
countries with underdeveloped health systems, such as Cambodia, community centred 
models of care may provide solutions to ensure all healthcare needs of individuals are met 
(Schneider and Lehmann, 2016).  
The delivery of chronic disease healthcare models has evolved in different ways across 
different settings. For example, in the United Kingdom (UK) primary care facilities are used 
in screening, initiating treatment, and monitoring. There is a strong focus on encouraging 
self-management for achieving disease control, and General Practitioners are incentivised 
with the Quality and Outcomes Framework (QOF) to screen patients (NHS Digital, 2020). 
However, in the UK, contact with the health services is frequent and people are offered 
health checks after the age of 40. In contrast, the United States of America (USA) provides 
the majority of management through secondary care facilities using national and private 
health insurance programs (Commonwealth Fund, 2016). In LMICs, strategies for dealing 
with NCDs are in their infancy, given the focus of healthcare provision has largely been on 
providing care for acute conditions. For screening, suggested approaches involve 
Community Healthcare Workers or similar cadre. However, these haven’t been widely rolled 
out in real world settings (Munshi, Christofides and Eyles, 2019; Ndou et al., 2013; Tang et 
al., 2014).  Many suggested approaches for treatment in LMICs developed in recent years 
include the diagonal approaches of integrating existing infectious disease services to 
manage long-term conditions. These services are largely run by non-governmental 
organisations and financed with out of pocket expenditure (Datta, Husain and Asma, 2019; 
Janssens et al., 2007).   Approaches specific to managing chronic diseases, via strengthened 
primary care infrastructures, have also begun to gain popularity, but are still often 
dependent on private funding grants rather than national revenue (Collins et al., 2019; Laar 
et al., 2019). Regardless of approach or setting, analyses have shown that large proportions 
of patients with diabetes or hypertension are lost at all stages of the cascade of care, from 
testing and diagnosis, to treatment, and ultimately control. In LMICs a large proportion are 
lost in the first stage of the cascade (testing) (Manne-Goehler et al., 2019; Pascal Geldsetzer, 
2019). Therefore, there is a need for innovative new healthcare models that address the 
common barriers to accessing healthcare throughout the cascade of care, from disease 
recognition to adequate treatment, including high out of pocket expenses or reliable 
medication supply (Joshi et al., 2008). Robust analyses of new programmes that aim to 
address the entire cascade are needed to inform the development of effective chronic 
disease management in LMICs. 
 
The author’s institute applies a unique healthcare model that utilises Peer Educators (PEs), 
patients with diabetes and/or hypertension themselves, to return to their local villages to 
screen and initiate management of fellow community members. Elsewhere, the role of PEs 
in diabetes and self-management has also been recognised in the last two decades 
(Brownson and Heisler, 2009) with increasingly robust data that shows impact (Debussche 
et al., 2018) The Programme structure also uses a Revolving Drug Fund (RDF), which 
stabilises essential medicine provision and creates a sustainable income source (Cross et al., 
1986; van Olmen et al., 2016; Murakami et al., 2001). The PE roles have since been 
formalised into the existing national health infrastructure of two Operational Districts (ODs) 
in Cambodia, with a view to expand, whereas the RDF management remains under the 
organisation of The Programme.  One previous study (Taniguchi et al., 2017) has examined 
clinical effectiveness of The Programme between 2007 – 2013 in Takeo province, where it 
first started a rural network.  Our paper expands on these clinical outcomes to include data 
until 2016 (a total of 8 years), and additionally to describe the long-term retention of 




The study population includes people aged over 18 years living in the largely rural Takeo 
province in Cambodia, who were screened and diagnosed with diabetes or hypertension. 
Takeo is sixth largest of the 25 provinces in Cambodia (population 899,485 [5.9%]) (National 
Institute of Statistics, 2019).  
Programme description: 
The Programme uses a community-centred approach to long-term care for diabetes and 
hypertension management.  Peer Educators (PEs), patients selected for their motivation, are 
trained to screen and manage these conditions in their local village and health centre 
catchment area. PEs carry out screening of people aged 40 years and over and are given 
small payments for travel (US$0.04 per km), registering new patients (US$0.12 per patient), 
and more recently measuring blood glucose (US$0.62 per patient) and blood pressure (BP) 
(US$0.12 per patient). Local guidelines define presence of diabetes as fasting blood glucose 
(FBG) ≥ 126mg/dl or post-prandial blood glucose (PPBG) ≥ 180mg/dl, and hypertension as 
systolic ≥ 140mmHg and diastolic ≥ 90 mmHg. Only patients with blood glucose or pressure 
results above these thresholds are enrolled in the program, all other adults in the household 
are advised to contact the peer educator if they notice symptoms of diabetes.  The role of 
PEs also includes arranging village health meetings to discuss lifestyle measures and diet.  
PEs are active in 21 of 100 Operational Districts (OD) of Cambodia and each OD is served by 
a referral hospital where physician-lead prescriptions are made. The Programme itself 
provides laboratory services and operates a RDF for vetted, reliable, and lower priced drugs 
supplied to contracted pharmacies. PEs act as an intermediary between the physician and 
less mobile patients to deliver and explain blood results, pick up prescriptions, and monitor 
blood sugars and pressures.  Early in its inception, in 2007, the program engaged at a 
national level to have PEs recognised as national healthcare workers; they were recognised 
in the National Strategic Plan for Prevention and Control of NCD 2013-2020 (Ministry of 
Health, 2012). The role of the PE has also been described in the ‘National Standard 
Operating Procedures for Diabetes and Hypertension in Primary Care’ (Ministry of Health, 
2019). However, training of PEs is still undertaken by The Programme with a view to 
transitioning this to the care of national services in the coming five years. 
Data: 
Data from all patients enrolled in Takeo province from 1st February 2007 to 31st March 2016 
were included in the study. Multiple electronic datasets containing enrolment data, 
laboratory results, doctors’ follow-up, and PE follow-up were merged. 
Variables captured at enrolment were: sex, age, whether prescription medication or 
traditional medicines were already being taken, smoking status, height and weight (using 
generic scales and a height measurement stick, and from which BMI was derived in kg/m2), 
fasting or post-prandial capillary blood glucose (mg/dl), and systolic and diastolic BP 
(mmHg). Capillary blood glucose variables were measured using 2007 Roche Accu-Chek, 
which was changed to ACON On Call Plus machine from 1st December 2009 onwards. HbA1c 
was measured in the laboratory using SIEMENS DCA. BP was measured using Automatic 
Citizen CH-432B machine in 2009, AS-35B in 2010, and in 2015 both ALP-K2 and Nissei SL 
1902. 
PEs classified patients with a fasting capillary blood glucose of ≥ 126mg/dl or post-prandial 
blood glucose of ≥ 180mg/dl as having diabetes. Patients with systolic BP ≥ 140mmHg and 
diastolic BP ≥ 90mmHg were classified as having hypertension. The clinical variables 
extracted from the follow up databases were systolic and diastolic BP (mmHg), capillary 
glucose reading of fasting blood glucose (FBG) (mg/dl), post-prandial blood glucose (PPBG) 




Our main outcomes were change in BP over time for patients enrolled into the program 
with hypertension. 
Other outcomes were (1) The population in the program enrolled with hypertension or 
diabetes who were controlled over time (2) loss to follow up of participants enrolled in the 
program 
Patients were defined as having either hypertension or diabetes based on the PE diagnosis. 
For hypertension, three disease groupings explored in the analyses were all people with 
hypertension (with or without diabetes), diabetes and hypertension (concurrent diabetes 
and hypertension), or hypertension alone (without diabetes). BP control at follow up was 
defined as systolic BP < 140mmHg and diastolic BP < 90mmHg (%). A separate analysis was 
done for patients with concurrent diabetes and hypertension, using a BP target of < 
130mmHg systolic and < 80mmHg diastolic as per clinical guidelines for patients with 
diabetes. 
For diabetes, all people with diabetes (with or without hypertension) were included.  Blood 
sugar controlled to target at follow up was defined, as per local guidelines, as FBG of ˂ 
130mg/dl, PPBG ˂ 180mg/dl or HBA1C ˂ 7%. In patients who had more than one form of 
blood sugar measurement at a given follow up time, HbA1c was chosen as the preferred 
measure, PPBG was the second preferred, and FBG was the least preferred, based on our 
latest understanding of the correlation of Point Of Care (POC) blood sugar testing with 
HbA1c levels (Ketema and Kibret, 2015) . 
Time to follow up was calculated as date of follow up visit minus enrolment date, in years to 
the nearest 6 months. Patients were categorised as lost to follow up (“left the programme”) 
if they had not reattended by one year after their last follow up date. Timepoint 0 
represents the date of enrolment. 
 
Explanatory variables 
Overweight was classified as having a BMI of ≥ 23kg/m2 to reflect lower BMI average in Asia 
(WHO expert consultation, 2004),  BMI of ≥ 25kg/m2 was also used to show comparison 
with global standards. BMI ≥ 30kg/m2 was defined as obese. Smoking was captured by self-
report and taken to mean current smoker. Participants with no response to the question on 
smoking were classed as non-smokers.  
Age-groups were categorised as aged under 60 or aged 60 and over. Whether on 
prescription or traditional medicine at baseline was captured as yes or no. In addition, the 
number of prescription medicines prescribed by the program to control BP or diabetes were 
captured as continuous variables at one-year post enrolment, as well as the maximum 
number of medications taken by each individual at any time point in the program. 
Analyses 
All data were analysed using open-source statistical program RStudio Inc – Version 1.0136 
2016 under public license. For all analyses, a two-sided p value of <0.05 was taken as 
significant. 
Entries with incomplete data – mostly missing follow up dates – or those with follow up 
dates that occurred before their enrolment day (incorrect data entry) were excluded from 
analyses. Outlier entries with systolic or diastolic BP ˂ 20mmHg were also excluded. Data 
are described as n (%) for categorical and mean (SD) for normally distributed variables (after 
testing for normality of distribution). 
For patients with hypertension, the systolic and diastolic BP (mmHg) change from baseline 
were computed using the follow up BP closest in time to each 6 monthly follow up time 
point. Where multiple BP recordings existed for a patient that were equally close to the 
follow-up year, the mean reading was used for analysis. The mean BP change from 
enrolment for all patients at each timepoint is displayed for each hypertension group and 
disaggregated by sex (male and female) and age-category (under 60 years and age 60 and 
over). 
A paired samples t-test was carried out to test significance of the mean change from 
baseline in systolic and diastolic BP at each timepoint and an unpaired t-test was carried out 
to test significance between male and female sex. 
Percentage of patients with systolic and diastolic BP within target range at each follow up 
time was displayed for each hypertension group. For all patients with hypertension, binary 
logistic regression was done using complete cases to assess the effects of explanatory 
variables; presence of diabetes, age group, sex, smoking status, BMI and number of 
medications for hypertension taken at the one-year time point, on whether hypertension 
was controlled to target.  
For all participants with diabetes, the percentage of patients with controlled diabetes at 
each follow up time was calculated. To explore associations with diabetes controlled to 
target, binary logistic regression was done using complete cases, using the explanatory 
variables; presence of hypertension, age group, sex, smoking status, BMI, and number of 
diabetes medications taken at the one-year time point.    
Given attrition rates decline with increased duration in a program, attrition rates were 
calculated dependent on year of follow-up (n, the ‘n’th year after enrolment) and the year 
(Y). Patients were defined as lost to follow up if they had not been seen in the year after 
their last visit, therefore, for any year, attrition rate, is the number of people enrolled in 
year ‘Y-n’, seen in year ‘Y-1’ and not seen in year ‘Y’, divided by the total number of people 
enrolled in year ‘Y-n’ who were seen in year ‘Y-1’.  
The formula used was as follows:  
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 𝐴𝐴𝑟𝑟𝐴𝐴𝑟𝑟 (𝐴𝐴,𝑌𝑌)
=
𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑟𝑟𝐴𝐴 𝐴𝐴𝑜𝑜 𝑝𝑝𝑟𝑟𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝑝𝑝𝑝𝑝𝑟𝑟𝐴𝐴𝐴𝐴𝑝𝑝 𝑟𝑟𝐴𝐴𝐴𝐴𝐴𝐴𝑙𝑙𝑙𝑙𝑟𝑟𝑙𝑙 𝐴𝐴𝐴𝐴 𝑦𝑦𝑟𝑟𝑟𝑟𝐴𝐴 (𝑌𝑌 − 𝐴𝐴),𝑜𝑜𝐴𝐴𝑙𝑙𝑙𝑙𝐴𝐴𝑓𝑓𝑟𝑟𝑙𝑙 𝑁𝑁𝑝𝑝 𝐴𝐴𝐴𝐴 𝑦𝑦𝑟𝑟𝑟𝑟𝐴𝐴 (𝑌𝑌 − 1) 𝑟𝑟𝐴𝐴𝑙𝑙 𝑁𝑁𝐴𝐴𝑝𝑝𝑝𝑝𝑟𝑟𝑙𝑙 𝑜𝑜𝐴𝐴𝑙𝑙𝑙𝑙𝐴𝐴𝑓𝑓 𝑁𝑁𝑝𝑝 𝐴𝐴𝐴𝐴 𝑦𝑦𝑟𝑟𝑟𝑟𝐴𝐴 𝑌𝑌
𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑟𝑟𝐴𝐴 𝐴𝐴𝑜𝑜 𝑝𝑝𝑟𝑟𝐴𝐴𝑝𝑝𝑙𝑙𝑟𝑟 𝑟𝑟𝐴𝐴𝐴𝐴𝐴𝐴𝑙𝑙𝑙𝑙𝑟𝑟𝑙𝑙 𝐴𝐴𝐴𝐴 𝑦𝑦𝑟𝑟𝑟𝑟𝐴𝐴 (𝑌𝑌 − 𝐴𝐴) 𝑟𝑟𝐴𝐴𝑙𝑙 𝑜𝑜𝐴𝐴𝑙𝑙𝑙𝑙𝐴𝐴𝑓𝑓𝑟𝑟𝑙𝑙 𝑁𝑁𝑝𝑝 𝐴𝐴𝐴𝐴 𝑦𝑦𝑟𝑟𝑟𝑟𝐴𝐴 (𝑌𝑌 − 1)
 
To explore the probability of any patients leaving the program at n years after enrolment, 
Cox regression analysis was done using complete cases with assumption of proportional 
hazards.  Data were censored for those who remained in the program for the full duration 
of the data period. Explanatory variables included in the model were disease type (diabetes 
alone, hypertension alone, diabetes and hypertension), sex, age group, BMI, smoking status, 
and total number of medications taken at one year. Kaplan-Meier survival plots were 
plotted for disease groups.  
This study is a retrospective exploratory analysis of real-world data and therefore no sample 
size calculation was carried out. 
RESULTS: 
9139 patients were enrolled in the programme between January 2007 and March 2016, of 
which 66.4% were female, mean age was 56.4 [SD 13.5], 80.3% had a diagnosis of 
hypertension, and 47.6% had a diagnosis of diabetes (see appendix table 1.0 for 
characteristics of all patients enrolled). 6677 patients had data available for inclusion in 
analyses (see appendix table 2 for characteristics of excluded patients). Depending on 
analysis, not all 6677 patients had information available, 57 patients were excluded from 
analyses of blood pressure due to missing blood pressure measurements and 10 patients 
were excluded from analyses of diabetes due to missing blood sugar measurements (figure 
1.0).  Of the total 6677 patients included, 59.2% (3956) had diabetes, 74.7% (4987) had 
hypertension, 34.5% (2302) had diabetes and hypertension and 40.2% (2685) had 
hypertension alone (table 1.0). 67.1% patients included were female and the mean patient 
age was 55.7 years (SD 12.9). 15.7% patients were taking traditional medicines at enrolment 
and 5.4% reported smoking. 46.2% of all patients (48.5% of patients with diabetes) were 
overweight (BMI > 23 kg/m2). The mean (SD) number of medications taken for hypertension 
or diabetes at the one-year time point was 1.1 (1.2) and 0.8 (1.0), respectively.   Mean (SD) 
maximum number of medications used to treat hypertension or diabetes in the program 
was 1.4 (1.3) and 1.0 (1.0), respectively (table 1.0). 
From the time of enrolment to their last review date, patients had between 1 and 84 follow-
up visits, with an average of 10.9 (SD 11.1) visits. 
Blood pressure control: 
For all patients with hypertension, change in BP (mmHg) from enrolment is shown in figure 
2.0 (appendix table 3.0 shows the maximum and mean BPs for the 1174 patients who had 
measurements that were equidistant from the 6-month analysis timepoint). The mean 
change in systolic and diastolic BP from baseline within the first year was -15.1mmHg (SD 
23.6, p <0.0001) and -8.6mmHg (SD 14.0, p <0.0001), respectively. The greatest fall in 
systolic blood pressure occurred at 2.5 years after enrolment, (-18.9 mmHg [SD 37.4, p 
<0.0001]) and at 3.5 years for diastolic BP (-11.4mmHg [SD 24.5, p <0.0001], figure 2.0). For 
patients who had diabetes and hypertension, mean change in BP from baseline 1 year after 
enrolment was -10.9mmHg (SD 22.9, p < 0.0001) systolic and -7.1mmHg (SD 12.9, p < 
0.0001) diastolic (appendix figure 1.0).  For patients with hypertension alone, mean change 
in BP from baseline at 1.0 year was -20.0mmHg (SD 24.5, p < 0.0001) systolic and -8.5mmHg 
(SD 14.2, p< 0.0001) diastolic (appendix figure 1.1).   
Considering all patients with hypertension, mean systolic or diastolic BP change from 
baseline was similar for males and females and for those older or younger than 60 years.  
(appendix figures 1.2 - 1.5).   
Percentages of all people with hypertension with systolic and diastolic BP controlled to 
target at each follow up time are shown in figure 3.0. The proportion of patients with 
controlled BP climbs steadily to a peak of 70.6% at 5.5 years. Appendix figure 2.0 shows 
control for patients with concurrent diabetes and hypertension within the target of < 130/< 
80 mmHg as per clinical guidelines. Binary logistic regression showed the presence of 
diabetes, being younger than 60 years old and smoking at enrolment were all significantly 
associated with having hypertension controlled at one year after enrolment. Whereas the 
number of antihypertensive medications taken, sex, and BMI were not significantly 
associated (appendix table 4.0).   
Blood sugar control 
The proportion of patients within blood sugar levels controlled remains stable throughout 
the study period (figure 3.0) at close to 40%.  Binary logistic regression showed number of 
anti-glycaemic medications and BMI were significantly associated with blood sugar control 
at one year. Presence of hypertension, age group, sex and smoking status were not 
significantly associated (appendix table 5.0). 
Attrition Rate 
The average time spent in the program for all patients was 2.3 years [SD 1.9]. Average rate 
of attrition within the first year after enrolment, across the 7-year period (2008 – 2015) was 
44.1% (SD 10.3, range 29.8% to 61.5%). Attrition in the 2nd year after enrolment ranged 
between 32.4% to 50.0% with a mean of 38.3% [SD 5.8] (figure 4.0). Cox Regression analyses 
results are shown in table 2.0. Those with hypertension alone were more likely to leave 
compared to those with diabetes alone. Age under 60 years was protective against leaving 
the programme as was those with higher BMI compared to those with BMI under 23 kg/m2. 
Those who reported smoking were more likely to leave the programme as were those who 
took between 1 and 3 medications for diabetes or hypertension at one year.  
figure 5.0 shows Kaplan-Meier plots of attrition for patients with hypertension, diabetes, or 
both hypertension and diabetes. 
DISCUSSION: 
The analyses show that a program using a revolving drug fund and peers to screen and 
follow up patients with hypertension and diabetes is effective at reducing BP and improving 
glycaemic control. However, retention in the program is low, with attrition being similar in 
each year after enrolment.  The focus on healthcare provision in many LMICs has been on 
improving care for infectious diseases and reducing maternal and neonatal mortality and 
morbidity. However, with the Sustainable Development Goals, has come a focus also on 
reducing premature mortality from non-communicable diseases and provision of universal 
health coverage (UHC). Unfortunately, the reality is that coverage of diseases under UHC, 
even in countries where this exists, may not extend to non-communicable diseases (The 
Lancet, 2014), and looking towards other models of ensuring access to medicines for people 
with these conditions remains a valuable lesson. Thus, even though The Programme uses an 
Out of Pocket payment system for ensuring medicines availability, our findings have 
important policy implications for other countries without UHC looking to scale up care for 
these diseases and suggest that although the model works in the short term, more needs to 
be done to encourage retention.  
The most rapid reduction in systolic and diastolic BP was within the first year of enrolling 
with The Programme; the comparatively lower reduction in diastolic compared to systolic 
BP is in keeping with our understanding of the effect of common antihypertensive agents 
(Wu et al., 2005).  However, sustained BP reduction was observed throughout the study 
period. Although we did not formally assess changes in cardiovascular risk over time, the 
increasing proportion of patients with BP and diabetes controlled over time suggests that 
patients enrolled within The Programme will have lowered their cardiovascular risk (NICE, 
2019).   
Our findings, with more patients and longer duration of follow up were similar to those 
previously found (Taniguchi et al., 2017).  Whilst it is disappointing that results haven’t 
improved over time, The Programme appears to achieve much higher levels of control 
compared to data analysed from the World Health Organizations (WHO) Study on Global 
Ageing and Adult Health (SAGE) where BP control ranged from 4.1% in Ghana to 14.1% in 
India (Lloyd-Sherlock et al., 2014). BP and diabetes control was also higher in The 
Programme than has been shown in analyses of the cascade of care in other South East 
Asian or LMIC settings (Chow et al., 2013; Geldsetzer et al., 2019; Manne-Goehler et al., 
2019). Our relatively positive findings may be a particularity of the societal context or 
relatively developed setting of Cambodia. However, a Cambodian Médecins San Frontier 
(MSF) clinic for Diabetes from 2002 to 2008  (Raguenaud et al., 2009) working in the same 
region as our programme, found only 24% patients achieved blood sugar control within one 
year. This suggests that the program itself had positive benefits, although whether these are 
due to the use of peer educators or a revolving drug fund is not possible to tell from our 
study.  The percentage control amongst The Programme is more comparable to those seen 
in a chronic care model implemented in Philippines called First-Line Diabetes Care 
(FiLDCare), which saw rates of control of 50.6% within six months. FiLDCare initiated self-
management education in local health facilities using existing community health workers to 
encourage self-management at the community level. in contrast to the author’s institute, 
The Philippines programme had the family physician being the primary contact for patients 
rather than the community health worker. The payments for medications in FiLDCare were 
also out of pocket although with a plan to become subsidised (Ku and Kegels, 2015).    
Experiences from settings where healthcare is free at the point of access suggest that cost 
of medications is not the only limiting factor to achieving diabetes control. For example, in 
the United Kingdom, where medications are either free or available for a small prescription 
charge rates of control were historically low; only 24% of people with diabetes had  blood 
glucose measurements within target levels between 1998 and 2002 (Fox et al., 2006). 
However, more recent data show control rates for type 2 diabetes as high as 66.8% in 2016-
17 (NHS Digital, 2018). Potentially, multiple factors lie behind this increase, including health 
education – with an increase in awareness of diabetes and hypertension in the general 
public over time (Falaschetti et al., 2014; Nazar et al., 2015; Li et al., 2010) and presence of 
pay for performance incentives for healthcare practitioners (Vaghela et al., 2009). Although 
health literacy in general and specifically relating to cardiovascular diseases and its risk 
factors hasn’t been formally assessed in The Programme, the use of PEs and the regular 
screening involved is likely to increase the knowledge of the general population. PEs are also 
paid on a per patient basis and this is likely to have a similar motivating effect to the UK pay 
for performance initiative.    
That The Programme’s outcomes compare favourably with those from other LMIC settings is 
encouraging. The focus of this paper was to illicit whether sustained reduction in clinical 
outcome measures were achieved in this real-world assessment of the programme and we 
are unable to comment on what aspects of it, e.g. peer educator or revolving drug fund, 
contribute to the favourable outcomes. Other analyses in LMIC provide evidence that PEs 
may contribute to improving glycaemic control, for example, a randomised control trial 
carried out in Mali where PEs delivered structured education programmes to promote self-
management showed higher levels of diabetes control (Debussche et al., 2018). The 
Programme’s own PEs were implemented to specifically address the screening and diagnosis 
of patients as well as aiming to reduce barriers in accessing care and medications (van 
Olmen et al., 2016). However, to what extent this influences clinical outcomes requires 
further research to ascertain, but this knowledge would enhance the applicability of 
elements of the chronic disease programme in other LMICs. Existing research supports the 
use of non-physician health workers, such as PEs, as a way of achieving key aspects of the 
WHO health system building blocks needed to deliver NCD care (Heller et al., 2019). Peer 
groups have also been trialled in women’s health programmes to improve maternal and 
child health (Lewycka et al., 2013) and use of peers may improve care by reducing distances 
to accessing care, increasing patient knowledge and empowerment for improving 
behaviours to combat cardiovascular risk factors (Khetan et al., 2017; Brownson and Heisler, 
2009; Tang et al., 2014). 
Despite the short-term success of The Programme, the attrition rates are unacceptably high 
given that diabetes and hypertension are usually lifelong conditions. In some LMIC settings, 
the lack of recognition of diabetes or hypertension as chronic conditions by patients, 
combined with the costs of medications leads to high attrition rates (Rachlis et al., 2016; 
Amira and Okubadejo, 2007; Buabeng, Matowe and Plange-Rhule, 2004). However, this isn’t 
always the case;  one hypertension management programme in Vietnam found drop-out 
was as low as 14.3% over two years (Nguyen et al., 2011) and the results from a diabetes 
management programme run in the same province of Takeo, by MSF, showed attrition over 
a 5-year period of 34% (Raguenaud et al., 2009). The reasons for the high attrition rate in 
The Programme need to be explored. Given that we didn’t have information about death of 
patients, and that a large proportion of those enrolled were over 60 years of age, it may be 
that the attrition rate could partly be explained by patient death, especially as the life 
expectancy in Cambodia is currently around 70 years. However, mortality is unlikely to be 
the only explanation and further qualitative research needs to be done to explore the 
reasons for leaving the programme and offer solutions. It is encouraging that over time we 
saw an overall decline in first-and second-year attrition for the programme. This may be 
related to The Programme’s evolution and improved practise, with additional increased 
funding as it scaled up in 2010.   
 
Study Limitations: 
This real-world study used secondary data, and data capture was designed for clinical 
service rather than research studies. There were changes to the programme’s data entry 
methodology over the period 2007 to 2016 linked with the set-up and expansion of The 
Programme, which led to gaps in data and some discrepancies with dating, which meant 
that large numbers of data entries had to be excluded between 2007 – 2009. The gaps in 
data and lack of information regarding reasons for leaving the program limits our ability to 
comment on causal factors for the results. The covariates included in our analyses were 
limited by the data that were available for the majority of patients. This limited, for 
example, our ability to reliably ascertain the influence of smoking status on attrition from 
the programme. In addition, we have no information regarding the patients’ use of 
alternative health services alongside The Programme, although our assumption is that it 
provided the majority of care for patients enrolled in the programme. There are low 
numbers of patients who were enrolled in the programme in the first few years of inception, 
which leads to low numbers of patients with data available for longer than six years. Some 
patients were already diagnosed with diabetes and/or hypertension, therefore our study 
can not assess the first two parts of the cascade (population prevalence to screened and 
screened to given diagnosis). However, assessing the latter parts of the cascade gives vital 
information about the ability of the health service to deliver good quality clinical care.   In 
addition, for the diabetes group there were multiple methods for analysing blood sugar 
used by The Programme, therefore we were only able to look at diabetes outcomes as a 
binary variable (control or not control) compared to blood pressure analyses which allowed 
for change in BP analyses. 
Death was not captured as an outcome, thus in our attrition analyses we were not able to 
distinguish between this and voluntarily leaving the program. Some of the improvements in 
outcomes seen may have been due to regression to the mean, however, given that this is an 
analysis of a real world program and treatments were given as they would be in clinical 
practice, we have not accounted for blood pressure at baseline in our analyses, as this 
would not be done in clinical practice to determine treatment success. Finally, it is also 
important to consider that in assessing the clinical effectiveness of novel chronic disease 
programmes, the possible adverse effects of overtreatment of both BP and blood sugar, 
which leads to hypotension and hypoglycaemia, need to be considered, especially amongst 
frail older persons (Monami et al., 2013). 
CONCLUSION: 
This study shows that the innovative use of peer educators and a revolving drug fund as part 
of a community centred chronic disease programme results in substantial and sustained 
rates of diabetes and hypertension control for patients who remain in the program.  The 
role of PEs at a village level reduces many barriers to accessing healthcare for the majority 
rural population in Cambodia. PEs bring point of care testing to village homes, act as a 
medium for long-term monitoring and drug prescription collection for less mobile patients, 
and share peer to peer health education at a local level.  The Programme could prove to be 
a model for implementation in other low middle-income settings, however, further research 
is needed to determine reasons for the variable attrition rates. 
REFERENCES: 
Amira, C. and Okubadejo, N. (2007) 'Factors influencing non-compliance with anti-hypertensive drug 
therapy in Nigerians'. 
Brownson, C. A. and Heisler, M. (2009) 'The Role of Peer Support in Diabetes Care and Self-
Management', The Patient: Patient-Centered Outcomes Research, 2(1), pp. 5-17. 
Buabeng, K. O., Matowe, L. and Plange-Rhule, J. (2004) 'Unaffordable drug prices: the major cause of 
non-compliance with hypertension medication in Ghana', J Pharm Pharmaceut Sci, 7(3), pp. 350-352. 
Chow, C. K., Teo, K. K., Rangarajan, S., Islam, S., Gupta, R., Avezum, A., Bahonar, A., Chifamba, J., 
Dagenais, G., Diaz, R., Kazmi, K., Lanas, F., Wei, L., Lopez-Jaramillo, P., Fanghong, L., Ismail, N. H., 
Puoane, T., Rosengren, A., Szuba, A., Temizhan, A., Wielgosz, A., Yusuf, R., Yusufali, A., McKee, M., 
Liu, L., Mony, P., Yusuf, S. and investigators, P. S. (2013) 'Prevalence, Awareness, Treatment, and 
Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income 
Countries', JAMA, 310(9), pp. 959-968. 
Collins, T. E., Nugent, R., Webb, D., Placella, E., Evans, T. and Akinnawo, A. (2019) 'Time to align: 
development cooperation for the prevention and control of non-communicable diseases', BMJ, 366, 
pp. l4499. 
Commonwealth Fund, T. (2016) The U.S Health Care System. International Health Care System 
Profiles: The Commonwealth Fund. Available at: 
https://international.commonwealthfund.org/countries/united_states/ (Accessed: 03 March 2020). 
Cross, P. N., Huff, M. A., Quick, J. D. and Bates, J. A. (1986) 'Revolving drug funds: Conducting 
business in the public sector', Social Science & Medicine, 22(3), pp. 335-343. 
Datta, B. K., Husain, M. J. and Asma, S. (2019) 'Assessing the relationship between out-of-pocket 
spending on blood pressure and diabetes medication and household catastrophic health 
expenditure: evidence from Pakistan', International Journal for Equity in Health, 18(1), pp. 9. 
Debussche, X., Besanc¸on, S., Balcou-Debussche, M., Ferdynus, C., Delisle, H. l., Huiart, L. and Sidibe, 
A. T. (2018) 'Structured peer-led diabetes self-management and support in low-income country: The 
ST2EP randomised control trial in Mali', PLoS  ONE, 13(1). 
Falaschetti, E., Mindell, J., Knott, C. and Poulter, N. (2014) 'Hypertension management in England: a 
serial cross-sectional study from 1994 to 2011', The Lancet, 383(9932), pp. 1912-1919. 
Fox, K. M., Gerber PharmD, R. A., Bolinder, B., Chen, J. and Kumar, S. (2006) 'Prevalence of 
inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general 
practice research database: A series of retrospective analyses of data from 1998 through 2002', 
Clinical Therapeutics, 28(3), pp. 388-395. 
Geldsetzer, P., Manne-Goehler, J., Marcus, M.-E., Ebert, C., Zhumadilov, Z., Wesseh, C. S., Tsabedze, 
L., Supiyev, A., Sturua, L., Bahendeka, S. K., Sibai, A. M., Quesnel-Crooks, S., Norov, B., Mwangi, K. J., 
Mwalim, O., Wong-McClure, R., Mayige, M. T., Martins, J. S., Lunet, N., Labadarios, D., Karki, K. B., 
Kagaruki, G. B., Jorgensen, J. M. A., Hwalla, N. C., Houinato, D., Houehanou, C., Msaidié, M., 
Guwatudde, D., Gurung, M. S., Gathecha, G., Dorobantu, M., Damasceno, A., Bovet, P., Bicaba, B. W., 
Aryal, K. K., Andall-Brereton, G., Agoudavi, K., Stokes, A., Davies, J. I., Bärnighausen, T., Atun, R., 
Vollmer, S. and Jaacks, L. M. (2019) 'The state of hypertension care in 44 low-income and middle-
income countries: a cross-sectional study of nationally representative individual-level data from 1·1 
million adults', The Lancet, 394(10199), pp. 652-662. 
Heller, D. J., Kumar, A., Kishore, S. P., Horowitz, C. R., Joshi, R. and Vedanthan, R. (2019) 'Assessment 
of Barriers and Facilitators to the Delivery of Care for Noncommunicable Diseases by Nonphysician 
Health Workers in Low- and Middle-Income Countries: A Systematic Review and Qualitative 
Analysis', JAMA Network Open, 2(12), pp. e1916545-e1916545. 
IHME (2017) Cambodia. Institute of Health Metrics and Evaluation [Website]. Available at: 
http://www.healthdata.org/cambodia (Accessed: 03 March 2020). 
Janssens, B., Van Damme, W., Raleigh, B., Gupta, J., Khem, S., Soy Ty, K., Vun, M., Ford, N. and 
Zachariah, R. (2007) 'Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic 
disease clinics in Cambodia', Bulletin of the World Health Organization, 85(11), pp. 880-885. 
Joshi, R., Jan, S., Wu, Y. and MacMahon, S. (2008) 'Global Inequalities in Access to Cardiovascular 
Health Care: Our Greatest Challenge', Journal of the American College of Cardiology, 52(23), pp. 
1817-1825. 
Ketema, E. B. and Kibret, K. T. (2015) 'Correlation of fasting and postprandial plasma glucose with 
HbA1c in assessing glycemic control; systematic review and meta-analysis', Archives of Public Health, 
73(1), pp. 43. 
Khetan, A. K., Purushothaman, R., Chami, T., Hejjaji, V., Madan Mohan, S. K., Josephson, R. A. and 
Webel, A. R. (2017) 'The Effectiveness of Community Health Workers for CVD Prevention in LMIC', 
Global Heart, 12(3), pp. 233-243.e6. 
Ku, G. M. V. and Kegels, G. (2015) 'Implementing elements of a context-adapted chronic care model 
to improve first-line diabetes care: effects on assessment of chronic illness care and glycaemic 
control among people with diabetes enrolled to the First-Line Diabetes Care (FiLDCare) Project in the 
Northern Philippines', Primary Health Care Research &amp; Development, 16(5), pp. 481-491. 
Laar, A. K., Adler, A. J., Kotoh, A. M., Legido-Quigley, H., Lange, I. L., Perel, P. and Lamptey, P. (2019) 
'Health system challenges to hypertension and related non-communicable diseases prevention and 
treatment: perspectives from Ghanaian stakeholders', BMC Health Services Research, 19(1), pp. 693. 
Lewycka, S., Mwansambo, C., Rosato, M., Kazembe, P., Phiri, T., Mganga, A., Chapota, H., Malamba, 
F., Kainja, E., Newell, M. L., Greco, G., Pulkki-Brännström, A. M., Skordis-Worrall, J., Vergnano, S., 
Osrin, D. and Costello, A. (2013) 'Effect of women's groups and volunteer peer counselling on rates 
of mortality, morbidity, and health behaviours in mothers and children in rural Malawi (MaiMwana): 
a factorial, cluster-randomised controlled trial', Lancet, 381(9879), pp. 1721-35. 
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M. and Zhang, X. (2010) 'Cost-effectiveness of 
interventions to prevent and control diabetes mellitus: a systematic review', Diabetes Care, 33(8), 
pp. 1872-94. 
Lloyd-Sherlock, P., Beard, J., Minicuci, N., Ebrahim, S. and Chatterji, S. (2014) 'Hypertension among 
older adults in low- and middle-income countries: prevalence, awareness and control', International 
Journal of Epidemiology, 43(1), pp. 116-128. 
Manne-Goehler, J., Geldsetzer, P., Agoudavi, K., Andall-Brereton, G., Aryal, K. K., Bicaba, B. W., 
Bovet, P., Brian, G., Dorobantu, M., Gathecha, G., Singh Gurung, M., Guwatudde, D., Msaidie, M., 
Houehanou, C., Houinato, D., Jorgensen, J. M. A., Kagaruki, G. B., Karki, K. B., Labadarios, D., Martins, 
J. S., Mayige, M. T., McClure, R. W., Mwalim, O., Mwangi, J. K., Norov, B., Quesnel-Crooks, S., Silver, 
B. K., Sturua, L., Tsabedze, L., Wesseh, C. S., Stokes, A., Marcus, M., Ebert, C., Davies, J. I., Vollmer, S., 
Atun, R., Bärnighausen, T. W. and Jaacks, L. M. (2019) 'Health system performance for people with 
diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally 
representative surveys', PLOS Medicine, 16(3), pp. e1002751. 
Ministry of Health, K. o. C., Ministry of Health (2012) National Strategic Plan for the Prevention and 
Control of Non-Communicable Diseases 2013-2020: Kingdom of Cambodia. 
Ministry of Health, K. o. C., Medicine, D.o.P. (2019) National Standard Operating Procedure for 
Diabetes and Hypertension Management in Primary Care 2019. 
Monami, M., Vitale, V., Lamanna, C., Bartoli, N., Martelli, D., Zannoni, S., Antenore, A., Toffanello, G., 
Marchionni, N. and Mannucci, E. (2013) 'HbA1c levels and all-cause mortality in type 2 diabetic 
patients: Epidemiological evidence of the need for personalised therapeutic targets', Nutrition, 
Metabolism and Cardiovascular Diseases, 23(4), pp. 300-306. 
Munshi, S., Christofides, N. J. and Eyles, J. (2019) 'Sub-national perspectives on the implementation 
of a national community health worker programme in Gauteng Province, South Africa', BMJ Global 
Health, 4(Suppl 10), pp. e001564. 
Murakami, H., Phommasack, B., Oula, R. and Sinxomphou, S. (2001) 'Revolving drug funds at front-
line health facilities in Vientiane, Lao PDR', Health Policy and Planning, 16(1), pp. 98-106. 
National Institute of Statistics, T. (2019) General Population Census of the Kingdom of Cambodia 
2019, Ministry of Planning, Kingdom of Cambodia: National Institute of Statistics. 
Nazar, C. M. J., Bojerenu, M. M., Safdar, M. and Marwat, J. (2015) 'Effectiveness of diabetes 
education and awareness of diabetes mellitus in combating diabetes in the United Kigdom; a 
literature review', Journal of nephropharmacology, 5(2), pp. 110-115. 
Ndou, T., van Zyl, G., Hlahane, S. and Goudge, J. (2013) 'A rapid assessment of a community health 
worker pilot programme to improve the management of hypertension and diabetes in Emfuleni sub-
district of Gauteng Province, South Africa', Global Health Action, 6(1), pp. 19228. 
Nguyen, Q. N., Pham, S. T., Nguyen, V. L., Wall, S., Weinehall, L., Bonita, R. and Byass, P. (2011) 
'Implementing a hypertension management programme in a rural area: local approaches and 
experiences from Ba-Vi district, Vietnam', BMC Public Health, 11(1), pp. 325. 
NHS Digital (2018) National Diabetes Audit, 2016-17 Report 1: Care Processess and Treatment 
Targets, NHS Digital. Available at: https://www.hqip.org.uk/wp-content/uploads/2018/03/National-
Diabetes-Audit-2016-17-Report-1-Care-Processes-and-Treatment-T....pdf  
NHS Digital (2020) QOF 2018/19 results. Quality and Outcomes Framework. NHS Digital. Available at: 
https://qof.digital.nhs.uk/. 
NICE, N. I. f. H. a. C. E. (2019) Hypertension in adults: diagnosis and management. NICE guideline 
NG136. Available at: https://www.nice.org.uk/guidance/ng136/evidence/d-targets-pdf-6896748209 
(Accessed: 13 Feb 2020). 
Pascal Geldsetzer, J. M.-G., Maja-Emilia Marcus, Cara Ebert, Zhaxybay Zhumadilov, Chea S Wesseh, 
Lindiwe Tsabedze, Adil Supiyev, Lela Sturua, Silver K Bahendeka, Abla M Sibai, Sarah Quesnel-Crooks, 
Bolormaa Norov, Kibachio J Mwangi, Omar Mwalim, Roy Wong-McClure, Mary T Mayige, Joao S 
Martins, Nuno Lunet, Demetre Labadarios, Khem Karki, Gibson B Kagaruki, Jutta M A Jorgensen, 
Nahla C Hwalla, Dismand Houinato, Corine Houehanou, Mohamed Msaidié, David Guwatudde, 
Mongal S Gurung, Gladwell Gathecha, Maria Dorobantu, Albertino Damasceno, Pascal Bovet, Brice 
W Bicaba, Krishna Aryal, Glennis Andall-Brereton, Kokou Agoudavi, Andrew Stokes, Justine I Davies, 
Till Barnighausen, Rifat Atun, Sebastian Vollmer, Linday M Jaacks (2019) 'The state of hypertension 
care in 44 low-income and middle-income countries: a cross-sectional study of nationally 
representative individual-level data from 1.1 million adults', The Lancet, 394(10199), pp. 652-662. 
Rachlis, B., Naanyu, V., Wachira, J., Genberg, B., Koech, B., Kamene, R., Akinyi, J. and Braitstein, P. 
(2016) 'Identifying common barriers and facilitators to linkage and retention in chronic disease care 
in western Kenya', BMC Public Health, 16(1), pp. 741. 
Raguenaud, M.-E., Isaakidis, P., Reid, T., Chy, S., Keuky, L., Arellano, G. and Van Damme, W. (2009) 
'Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-
year study', BMC medicine, 7, pp. 33. PubMed. DOI: 10.1186/1741-7015-7-33 (Accessed 2009). 
Schneider, H. and Lehmann, U. (2016) 'From Community Health Workers to Community Health 
Systems: Time to Widen the Horizon?', Health Systems & Reform, 2(2), pp. 112-118. 
Sophal Oum, P. R. P., Eng Mony Khuon, Vannareth Mey, Sothea Aim, Youttiroung Bounchan, 
Sovannara Cin, Linda Pen, Sathia Loun (2010) Prevalence of Non-communicable Disease Risk Factors 
in Cambodia: University of Health Sciences, Preventive Medicine Department of the Ministry of 
Health, Kingdom of Cambodia. 
Tang, T. S., Funnell, M., Sinco, B., Piatt, G., Palmisano, G., Spencer, M. S., Kieffer, E. C. and Heisler, M. 
(2014) 'Comparative Effectiveness of Peer Leaders and Community Health Workers in Diabetes Self-
management Support: Results of a Randomized Controlled Trial', Diabetes Care, 37(6), pp. 1525. 
Taniguchi, D., LoGerfo, J., van Pelt, M., Mielcarek, B., Huster, K., Haider, M. and Thomas, B. (2017) 
'Evaluation of a multi-faceted diabetes care program including community-based peer educators in 
Takeo province, Cambodia, 2007-2013', PLOS ONE, 12(9), pp. e0181582. 
The Lancet (2014) 'Grand convergence: a future sustainable development goal?', The Lancet, 
383(9913), pp. 187. 
Vaghela, P., Ashworth, M., Schofield, P. and Gulliford, M. C. (2009) 'Population Intermediate 
Outcomes of Diabetes Under Pay-for-Performance Incentives in England From 2004 to 2008', 
Diabetes Care, 32(3), pp. 427-429. 
van Olmen, J., Eggermont, N., van Pelt, M., Hen, H., de Man, J., Schellevis, F., Peters, D. H. and 
Bigdeli, M. (2016) 'Patient-centred innovation to ensure access to diabetes care in Cambodia: the 
case of MoPoTsyo', Journal of Pharmaceutical Policy and Practice, 9(1), pp. 1. 
WHO (2016) Cambodia. World Health Organization. Available at: 
https://www.who.int/diabetes/country-profiles/khm_en.pdf. 
WHO (2018) Noncommunicable diseases country profiles 2018. Geneva: World Health Organization, 
p. 223 p. 
WHO expert consultation (2004) 'Appropriate body-mass index for Asian populations and its 
implications for policy and intervention strategies', The Lancet, 363(9403), pp. 157-163. 
World Bank (2020) Cambodia Home, Overview. The World Bank In Cambodia. Worldbank.org 
[Website]. Available at: https://www.worldbank.org/en/country/cambodia/overview (Accessed: 
20/08/2020 2020). 
Wu, J., Kraja, A. T., Oberman, A., Lewis, C. E., Ellison, R. C., Arnett, D. K., Heiss, G., Lalouel, J.-M., 
Turner, S. T., Hunt, S. C., Province, M. A. and Rao, D. C. (2005) 'A Summary of the Effects of 
Antihypertensive Medications on Measured Blood Pressure', American Journal of Hypertension, 
18(7), pp. 935-942. 
 
 
